Minoo, Japan

Masato Tanaka

This inventor holds 1 USPTO granted patent. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masato Tanaka. Retrieved from https://idiyas.com/inventor/masato-tanaka-1ukrcw28

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Masato Tanaka

Introduction

Masato Tanaka is a notable inventor based in Minoo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. His work focuses on apoptosis regulation, which is crucial for various medical applications.

Latest Patents

Tanaka holds a patent for a Fas ligand derivative. This invention provides a soluble Fas ligand that functions as a Fas antagonist or an apoptosis regulator. The novel Fas ligand derivative exhibits excellent apoptosis-inducing activity and cytotoxic activity. Additionally, it includes a DNA encoding such a peptide, which enhances its potential for therapeutic use.

Career Highlights

Masato Tanaka is associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research and innovations. His work has been instrumental in developing new treatments that leverage the mechanisms of apoptosis for medical benefits.

Collaborations

Tanaka collaborates with Shigekazu Nagata, a fellow researcher, to further explore the applications of their findings in the pharmaceutical industry.

Conclusion

Masato Tanaka's contributions to the field of biotechnology, particularly through his patent on the Fas ligand derivative, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…